STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] CONMED Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

CONMED (CNMD) received a Form 144 notice indicating a planned sale of restricted securities by an affiliate. The filer intends to sell 3,500 shares of common stock through Fidelity Brokerage Services LLC, with an aggregate market value $150,500.00. The shares are listed on the NYSE, with an approximate sale date of 11/06/2025.

The securities were acquired on 10/31/2025 via restricted stock vesting from the issuer as compensation. As context, shares outstanding were 30,954,963. In the prior three months, the seller reported a sale of 598 shares on 08/07/2025 for $31,365.10.

Form 144 is a notice of proposed sale and does not involve proceeds to the company.

Positive
  • None.
Negative
  • None.

Insights

Routine Form 144 for 3,500 shares; neutral impact.

This filing signals an affiliate’s intent to sell 3,500 CONMED common shares with an $150,500.00 aggregate value. The shares were acquired via restricted stock vesting on 10/31/2025 as compensation, and the sale is planned for 11/06/2025 on the NYSE.

Form 144 notices are administrative and indicate potential sales under Rule 144. The issuer listed 30,954,963 shares outstanding, providing scale context for the proposed sale size.

Actual market impact depends on execution details and trading volume; the filing does not specify timing beyond the approximate sale date or method beyond using Fidelity as broker.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Conmed Corp

NYSE:CNMD

CNMD Rankings

CNMD Latest News

CNMD Latest SEC Filings

CNMD Stock Data

1.37B
30.77M
0.58%
114.87%
6.75%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
LARGO